Shares of Ascendis Pharma ASND lost more than 5% on Tuesday after management announced that the FDA extended the review period for its regulatory submission of a hormone replacement therapy …
RAMAT GAN, Israel, May 9, 2024–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a portfolio of proprietary small molecule drugs that treat oncology and inflammatory diseases, …
MANILA, Philippines – The Philippine Food and Drug Administration (FDA) has issued a second recall order for the imported chemotherapy drug Trexasaph after more of its batches were found to …
Phase 2 The clinical study is expected to begin in mid-2024 Organization of KOL virtual event “Beyond GLPs”. May 8, 2024 CRANBURY, NJ, May 2, 2024 /PRNewswire/ — Palatin Technologies, …
Experts have accused Andrew Huberman, the popular health influencer and neuroscientist recently embroiled in a sex scandal, of pushing expensive and “unscientific” supplements. DailyMail.com has discovered that Dr. Huberman, who …
ATLANTA – It’s a popular drug that millions of people take to lose weight, but the federal government and doctors are warning users about some versions of the drug Ozempic, …
The Food and Drug Administration has ended a split plan to regulate laboratory medical tests, including some used to diagnose cancer and Alzheimer’s disease, over concerns about reliability and risks …
The Food and Drug Administration on Wednesday approved the sale of an antibiotic to treat urinary tract infections in women, giving US health care providers a powerful new tool to …